Osteossarcoma periosteal: estudo de quatro casos

David, Alexandre; Rios, Aldemar Roberto; Tarrago, Ricardo P; Abreu, Armando de; Dorsch, Alexxandra Cezimbra; Alberti, Simone Zambelli.
Rev. bras. ortop ; 38(10): 623-633, out. 2003. ilus
Artículo en Portugués | LILACS | ID: lil-356700

Documentos relacionados

  1. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
  2. RhRu Alloy-Anchored MXene Nanozyme for Synergistic Osteosarcoma Therapy.
  3. Ferroptosis defense mechanisms: The future and hope for treating osteosarcoma.
  4. Overview of CD70 as a Potential Therapeutic Target for Osteosarcoma.
  5. Diverse cell death patterns-related signature for predicting prognosis and drug sensitivity of osteosarcoma patients.
  6. Deep Learning-Based Objective and Reproducible Osteosarcoma Chemotherapy Response Assessment and Outcome Prediction.
  7. Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
  8. Radiopharmaceuticals for Treatment of Osteosarcoma.
  9. Engineered bone marrow as a clinically relevant ex vivo model for primary bone cancer research and drug screening.
  10. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.